
Strides Pharma Science Ltd is Rated Hold
2026-11-11 10:10:52Strides Pharma Science Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 19 October 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 11 November 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read MoreStrides Pharma Gains 5.63%: Key Events and Margin Pressures Shape Weekly Performance
2026-10-31 16:03:25Key Events This Week 26 Oct: Stock opens strong at Rs.1,031.55 (+1.92%) 27 Oct: Intraday high of Rs.1,112 with 7.52% surge 30 Oct: Intraday low of Rs.989.3 amid price pressure 30 Oct: Flat quarterly performance reported with margin concerns Week OpenRs.1,012.15 Week CloseRs.1,069.15<div c...
Read More
Strides Pharma Science Ltd is Rated Hold
2026-10-31 10:10:24Strides Pharma Science Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 19 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Strides Pharma Science Ltd Reports Flat Quarterly Performance Amid Margin Pressures
2026-10-30 11:00:19Strides Pharma Science Ltd has reported a flat financial performance for the quarter ended September 2026, marking a notable shift from its previously positive growth trajectory. Despite achieving record-high sales and operating cash flows, the company’s margin expansion has stalled, leading to a downgrade in its Mojo Grade from Buy to Hold.
Read More
Strides Pharma Science Ltd Hits Intraday Low Amid Price Pressure
2026-10-30 10:51:59Strides Pharma Science Ltd experienced significant intraday weakness on 30 Oct 2026, with its stock price touching a low of Rs 989.3, marking a decline of 9.85% from the previous close. The stock underperformed its sector and the broader market, reflecting immediate selling pressure and subdued market sentiment within the Pharmaceuticals & Biotechnology space.
Read More
Strides Pharma Science Ltd Surges 7.52% to Day's High of Rs 1112 — Outperforms Sector by 6.73 Percentage Points
2026-10-27 12:01:37The Sensex remained nearly flat, edging down just 0.01%, while Strides Pharma Science Ltd surged 7.52% on 27 Oct 2026, hitting an intraday high of Rs 1112. This 6.73 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally rather than a broad market move.
Read MoreStrides Pharma Falls 3.61%: 3 Key Factors Driving the Weekly Decline
2026-10-17 16:01:13Key Events This Week 12 Oct: Stock opens strong at ₹1,096.05 (+1.19%) amid technical upgrades 13 Oct: Mojo Grade upgraded to Buy; price peaks at ₹1,098.05 (+0.18%) 15 Oct: Technical momentum shifts to mildly bullish; price drops 2.14% 16 Oct: Week closes lower at ₹1,044.10 (-1.59%) despite Sensex gains Week OpenRs.1,083.20 ...
Read More
Strides Pharma Science Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-10-15 08:02:48Strides Pharma Science Ltd has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from a bullish to a mildly bullish trend. Despite a modest decline in the stock price, the company’s technical parameters reveal a complex interplay of bullish and bearish signals across weekly and monthly timeframes, warranting a detailed analysis for investors navigating the Pharmaceuticals & Biotechnology sector.
Read More
Strides Pharma Science Ltd Upgraded to Buy on Strong Technical and Financial Performance
2026-10-13 08:40:53Strides Pharma Science Ltd has been upgraded from a Hold to a Buy rating, reflecting significant improvements across technical indicators, valuation metrics, financial trends, and overall quality. This upgrade, effective from 12 Oct 2026, is underpinned by robust quarterly results, sustained long-term growth, and bullish technical signals, positioning the small-cap pharmaceutical company favourably against its peers and broader market benchmarks.
Read MoreShareholder Meeting / Postal Ballot-Notice of Postal Ballot
18-Nov-2026 | Source : BSENotice of Postal Ballot seeking Shareholders approval for appointment of Mr. Biren Chandrakant Gabhawala as an Independent Director of the Company.
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
02-Nov-2026 | Source : BSETranscript of Earnings Call pertaining of Unaudited Financial Results of the Company for the quarter and half year ended September 30 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
30-Oct-2026 | Source : BSENewspaper Advertisement - Unaudited Financial Results for the quarter and half year ended September 30 2026
Corporate Actions
No Upcoming Board Meetings
Strides Pharma Science Ltd has declared 50% dividend, ex-date: 31 Jul 26
No Splits history available
No Bonus history available
No Rights history available